MASP2 and COVID-19: Prominent activation of complement pathways, including the lectin (MASP-2 [MBL-associated serine protease 2]), classical, alternative, and terminal pathways, has been observed in the lungs, skin, and sera of SARS-CoV-2–infected individuals, suggesting that the complement system is a pathological trigger of COVID-19 (20, 21).